$ESNT

Essent Group Ltd. Stock 12‑Month Price Target Raised to $70.75, Implies 8% Upside

Analyst estimates for Essent Group Ltd. raised its 12-month average price target to $70.75 from $68.75, based on 8 analysts. Targets range from $62 to $78. Using the Aug. 6 close, the update implies about 8% upside. The consensus rating remains “Buy” with 4 Buys, 5 Holds, and 0 Sells.

Original reporting
Published Aug 7, 2026, 11:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 7:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Essent Group Ltd. Stock 12‑Month Price Target Raised to $70.75, Implies 8% Upside — source image
Decision brief

The 30-second read

$ESNTBullishLow
01

Why it matters

A higher average target and unchanged “Buy” consensus can marginally improve sentiment, but it does not change the company’s disclosed fundamentals in the text.

02

Market read

Traders may treat this as mild sentiment support rather than a catalyst for repricing based on new fundamentals.

03

What to watch

The article does not specify the rationale behind the PT change, nor whether estimates for earnings, book value, or underwriting assumptions moved.

Relevance 4/10Novelty 4/10Timing: after-hours/overnight, based on Aug. 6 close and updated PT consensus

Background

The piece summarizes FactSet-sourced analyst consensus for Essent Group’s 12-month price target and rating distribution.

Company-level read

Ticker impact

$ESNTBullishMedium confidence
Context

Essent Group’s 12-month average analyst price target rose from $68.75 to $70.75, implying about 8% upside from the Aug. 6 close.

Expected impact

Modest upward bias for sentiment, with limited follow-through unless accompanied by new company fundamentals.

Evidence & confidence

The article only reports analyst estimate changes (target and rating mix) without new earnings, guidance, or operational catalysts.

Market effects

Minimal, since it is a single-name analyst target update without sector-wide new information.

None indicated; no regional macro or regulatory linkage provided.

None indicated; the update is localized to Essent’s analyst consensus.

Counterpoint

Analyst target revisions can lag or reflect already-known expectations; without new company data, price may not follow.

Key entities

  • Essent Group Ltd.

    Subject of the article, with updated analyst price target and consensus rating mix.

Related articles

$ESNTMedAI 8/10

Essent Group (NYSE:ESNT) Delivers Strong Q2 CY2026 Numbers

Essent Group (NYSE:ESNT) reported Q2 2026 revenue of $362.7 million, up 13.6% year on year, beating Wall Street estimates by 9.7%. GAAP profit was $2.08 per share, 19.3% above consensus. The article also cites book value per share growth of about 11.7% over five years and notes the stock rose 2.4% to $67.08 after results.

$ESNTMed

Unilever, Barclays & Shell: Markets live

Unilever (ULVR) shares rose after it upgraded full-year outlook on improving sales. It reported €25.6bn revenue and €4.66bn pre-tax profit for six months to 30 June, with underlying sales up 4.8%. Other FTSE movers included Barclays (BARC) guidance and buyback, Forterra (FORT) results, and Canal+ (CAN) profit jump tied to MultiChoice consolidation.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).